Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125017013 | 12501701 | 3 | F | 20160912 | 20160627 | 20160919 | EXP | US-ASTRAZENECA-2016SE69562 | ASTRAZENECA | 0.00 | F | Y | 54.90000 | KG | 20160919 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125017013 | 12501701 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1 PUFF TWICE DAILY | 1150018 | 202450 | INHALATION POWDER | ||||||||
| 125017013 | 12501701 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | Y | U | 0 | |||||||||
| 125017013 | 12501701 | 3 | C | IPRATROPIUM BROMIDE. | IPRATROPIUM BROMIDE | 1 | TWICE DAILY | 0 | |||||||||||
| 125017013 | 12501701 | 4 | C | CHOLESTEROL MEDICATION | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 125017013 | 12501701 | 5 | C | WATER PILL | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 125017013 | 12501701 | 6 | C | PNEUMOCOCCAL VACCINE POLYVALENT NOS | PNEUMOCOCCAL VACCINE POLYVALENT | 1 | 0 | ||||||||||||
| 125017013 | 12501701 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 20 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125017013 | 12501701 | 1 | Chronic obstructive pulmonary disease |
| 125017013 | 12501701 | 2 | Chronic obstructive pulmonary disease |
| 125017013 | 12501701 | 3 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125017013 | 12501701 | OT |
| 125017013 | 12501701 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125017013 | 12501701 | Body height decreased | |
| 125017013 | 12501701 | Device malfunction | |
| 125017013 | 12501701 | Malaise | |
| 125017013 | 12501701 | Palpitations | |
| 125017013 | 12501701 | Renal cancer stage IV | |
| 125017013 | 12501701 | Sinusitis | |
| 125017013 | 12501701 | Tremor | |
| 125017013 | 12501701 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125017013 | 12501701 | 1 | 201604 | 0 | ||
| 125017013 | 12501701 | 2 | 201602 | 0 | ||
| 125017013 | 12501701 | 6 | 20160223 | 0 |